Literature DB >> 28983934

Free dug concentrations in pregnancy: Bound to measure unbound?

Stein Schalkwijk1,2, Rick Greupink2, David Burger1.   

Abstract

Keywords:  albumin; antiretrovirals; pharmacokinetics; pregnancy; protein binding

Mesh：

Substances：

Year:  2017        PMID： 28983934      PMCID： PMC5698572          DOI： 10.1111/bcp.13432

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  Free drug fraction vs free drug concentration: a matter of frequent confusion.

Authors:  P L Toutain; A Bousquet-Melou
Journal:  J Vet Pharmacol Ther       Date:  2002-12       Impact factor: 1.786

2.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 3.  Monitoring free drug concentrations: challenges.

Authors:  Florin Marcel Musteata
Journal:  Bioanalysis       Date:  2011-08       Impact factor: 2.681

4.  Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?

Authors:  D Metsu; P L Toutain; E Chatelut; P Delobel; P Gandia
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

5.  Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

Authors:  Catia Marzolini; Laurent Decosterd; Ursula Winterfeld; Frédéric Tissot; Katyuska Francini; Thierry Buclin; Françoise Livio
Journal:  Br J Clin Pharmacol       Date:  2017-05-16       Impact factor: 4.335

Review 6.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.

Authors:  Moti Ramgopal; Olayemi Osiyemi; Carmen Zorrilla; Herta M Crauwels; Robert Ryan; Kimberley Brown; Vera Hillewaert; Bryan Baugh
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

8.  Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.

Authors:  Angela Colbers; José Moltó; Jelena Ivanovic; Kabamba Kabeya; David Hawkins; Andrea Gingelmaier; Graham Taylor; Katharina Weizsäcker; S Tariq Sadiq; Marchina Van der Ende; Carlo Giaquinto; David Burger
Journal:  J Antimicrob Chemother       Date:  2014-10-17       Impact factor: 5.790

9.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Authors:  Claire L Townsend; Laura Byrne; Mario Cortina-Borja; Claire Thorne; Annemiek de Ruiter; Hermione Lyall; Graham P Taylor; Catherine S Peckham; Pat A Tookey
Journal:  AIDS       Date:  2014-04-24       Impact factor: 4.177

10.  Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.

Authors:  Aurélie Fayet-Mello; Thierry Buclin; Nicole Guignard; Sandra Cruchon; Matthias Cavassini; Claudia Grawe; Erika Gremlich; Karoline Aebi Popp; Flavia Schmid; Chin B Eap; Amalio Telenti; Jérôme Biollaz; Laurent A Decosterd; Begoña Martinez de Tejada
Journal:  Antivir Ther       Date:  2012-08-22
View more
  11 in total

1.  Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.

Authors:  Stein Schalkwijk; Rob Ter Heine; Angela Colbers; Edmund Capparelli; Brookie M Best; Tim R Cressey; Rick Greupink; Frans G M Russel; José Moltó; Mark Mirochnick; Mats O Karlsson; David M Burger
Journal:  J Antimicrob Chemother       Date:  2019-05-01       Impact factor: 5.790

2.  Free dug concentrations in pregnancy: Bound to measure unbound?

Authors:  Stein Schalkwijk; Rick Greupink; David Burger
Journal:  Br J Clin Pharmacol       Date:  2017-10-06       Impact factor: 4.335

Review 3.  An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.

Authors:  Ahizechukwu C Eke
Journal:  J Basic Clin Physiol Pharmacol       Date:  2021-12-08

4.  Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.

Authors:  Paul Ken Leong Chin; Philip George Drennan; Sharon Jane Gardiner; Mei Zhang; Simon Charles Dalton; Stephen Thomas Chambers; Evan James Begg
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

Review 5.  Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Authors:  Vera E Bukkems; Angela Colbers; Catia Marzolini; Jose Molto; David M Burger
Journal:  Clin Pharmacokinet       Date:  2020-10       Impact factor: 6.447

6.  Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis.

Authors:  Richard Court; Kamunkhwala Gausi; Buyisile Mkhize; Lubbe Wiesner; Catriona Waitt; Helen McIlleron; Gary Maartens; Paolo Denti; Marian Loveday
Journal:  Br J Clin Pharmacol       Date:  2022-05-26       Impact factor: 3.716

7.  A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.

Authors:  Stein Schalkwijk; Rob Ter Heine; Angela C Colbers; Alwin D R Huitema; Paolo Denti; Kelly E Dooley; Edmund Capparelli; Brookie M Best; Tim R Cressey; Rick Greupink; Frans G M Russel; Mark Mirochnick; David M Burger
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

Review 8.  Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

Authors:  Ruben van der Galiën; Rob Ter Heine; Rick Greupink; Stein J Schalkwijk; Antonius E van Herwaarden; Angela Colbers; David M Burger
Journal:  Clin Pharmacokinet       Date:  2019-03       Impact factor: 6.447

Review 9.  Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child.

Authors:  Jolien J M Freriksen; Minou van Seyen; Ali Judd; Diana M Gibb; Intira J Collins; Rick Greupink; Frans G M Russel; Joost P H Drenth; Angela Colbers; David M Burger
Journal:  Aliment Pharmacol Ther       Date:  2019-08-25       Impact factor: 8.171

10.  A population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIV.

Authors:  Vera E Bukkems; Teun M Post; Angela P Colbers; David M Burger; Elin M Svensson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.